References
- Bolton-MaggsPHPasiKJHaemophilias A and BLancet200336193711801180912781551
- Manco-JohnsonMJAbshireTCShapiroADProphylaxis versus episodic treatment to prevent joint disease in boys with severe hemophiliaN Engl J Med2007357653554417687129
- KrishnanSVietriJFurlanRDuncanNAdherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient surveyHaemophilia2015211647025470071
- SrivastavaABrewerAKMauser-BunschotenEPTreatment Guidelines Working Group on Behalf of The World Federation Of HemophiliaGuidelines for the management of hemophiliaHaemophilia2013191e1e4722776238
- BerntorpEDolanGHayCEuropean retrospective study of real-life haemophilia treatmentHaemophilia201723110511427761962
- MorfiniMBensonGJiménez-YusteVTailoring care to haemophilia patients’ needs: which specialty and when?Blood Transfus201513464465026057493
- OladapoAOEpsteinJDWilliamsEItoDGringeriAValentinoLAHealth-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trialsHaemophilia2015215e344e35826390060
- CiminoELinariSMalerbaMHalimehSBiondoFWestfeldMPatient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countriesPatient Prefer Adherence201481713172025525348
- SaxenaKBarriers and perceived limitations to early treatment of hemophiliaJ Blood Med20134495623700376
- RingwaldJRudolphPBinerMTravel behaviour of patients with haemophiliaTravel Med Infect Dis201311315916523608460
- DiBenedettiDBColesTMSharmaTPericleousLKulkarniRAssessing patients’ and caregivers’ perspectives on stability of factor VIII products for haemophilia A: a web-based study in the United States and CanadaHaemophilia2014204e296e30324870350
- KappelgaardAMMetzingerCPSchnabelDA web-based survey assessing the impact of storage flexibility on the daily life of patients and caregivers administering growth hormoneExpert Rev Med Devices201512551752726186495
- ChauguleSSHayJWYoungGUnderstanding patient preferences and willingness to pay for hemophilia therapiesPatient Prefer Adherence201591623163026635471
- Fernández-AriasIKimHKFactor VIII delivery devices in haemophilia A. Barriers and drivers for treatment adherenceFarm Hosp201640n0657960327894230
- FurlanRKrishnanSVietriJPatient and parent preferences for characteristics of prophylactic treatment in hemophiliaPatient Prefer Adherence201591687169426648701
- MahlanguJPowellJSRagniMVA-LONG InvestigatorsPhase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia ABlood2014123331732524227821
- CollinsPWPersonalized prophylaxisHaemophilia201218Suppl 413113522726096
- DunnAThe long and short of it: using the new factor productsHematology Am Soc Hematol Educ Program20152015263226637697
- NovaisTDuclosAVarinRLopezIChamouardVTreatment-related knowledge and skills of patients with haemophilia and their informal caregiversInt J Clin Pharm2016381616926474860
- FarrugiaASafety issues of plasma-derived products for treatment of inherited bleeding disordersSemin Thromb Hemost201642558358827077709
- FranchiniMCoppolaARocinoAPerceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE surveyHaemophilia2014202e128e13524533954
- KamionkaMEngineering of therapeutic proteins production in Escherichia coliCurr Pharm Biotechnol201112226827421050165
- SantagostinoEAuerswaldGBensonGSwitching treatments in haemophilia: is there a risk of inhibitor development?Eur J Haematol201594428428925135593
- ArmstrongEPMaloneDCKrishnanSWesslerMJAdherence to clotting factors among persons with hemophilia A or BHematology201520314815325001343
- ThornburgCDPhysicians’ perceptions of adherence to prophylactic clotting factor infusionsHaemophilia2008141252918028395
- WitkopMLMcLaughlinJMAndersonTLMunnJELambingATortellaBPredictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorderHaemophilia2016224e245e25027216992
- LjungRAuerswaldGBensonGNovel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patientsHaemophilia201319448148623387528